"Fatty Liver" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.
Descriptor ID |
D005234
|
MeSH Number(s) |
C06.552.241
|
Concept/Terms |
Steatohepatitis- Steatohepatitis
- Steatohepatitides
- Steatosis of Liver
- Visceral Steatosis
- Steatoses, Visceral
- Steatosis, Visceral
- Visceral Steatoses
- Liver Steatosis
- Liver Steatoses
- Steatoses, Liver
- Steatosis, Liver
|
Below are MeSH descriptors whose meaning is more general than "Fatty Liver".
Below are MeSH descriptors whose meaning is more specific than "Fatty Liver".
This graph shows the total number of publications written about "Fatty Liver" by people in this website by year, and whether "Fatty Liver" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 0 | 1 |
1999 | 3 | 0 | 3 |
2001 | 1 | 2 | 3 |
2002 | 1 | 1 | 2 |
2003 | 1 | 1 | 2 |
2004 | 1 | 1 | 2 |
2005 | 4 | 1 | 5 |
2006 | 9 | 1 | 10 |
2007 | 6 | 1 | 7 |
2008 | 6 | 2 | 8 |
2009 | 10 | 3 | 13 |
2010 | 8 | 6 | 14 |
2011 | 13 | 5 | 18 |
2012 | 11 | 9 | 20 |
2013 | 9 | 5 | 14 |
2014 | 5 | 1 | 6 |
2015 | 3 | 1 | 4 |
2016 | 2 | 4 | 6 |
2017 | 3 | 3 | 6 |
2018 | 4 | 3 | 7 |
2019 | 4 | 0 | 4 |
2020 | 3 | 2 | 5 |
2021 | 4 | 1 | 5 |
2023 | 1 | 0 | 1 |
2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fatty Liver" by people in Profiles.
-
Association between food insecurity and metabolic dysfunction-associated steatotic liver disease/significant fibrosis measured by fibroscan. Eur J Nutr. 2024 Apr; 63(3):995-1001.
-
A public health perspective on mitigating the global burden of chronic liver disease. Hepatology. 2024 Feb 01; 79(2):451-459.
-
Associations between alcohol consumption and hepatic steatosis in the USA. Liver Int. 2021 09; 41(9):2020-2023.
-
?2-Adrenergic receptor agonist induced hepatic steatosis in mice: modeling nonalcoholic fatty liver disease in hyperadrenergic states. Am J Physiol Endocrinol Metab. 2021 07 01; 321(1):E90-E104.
-
Discovery of a Vitamin D Receptor-Silent Vitamin D Derivative That Impairs Sterol Regulatory Element-Binding Protein In Vivo. J Med Chem. 2021 05 13; 64(9):5689-5709.
-
Calcium supplementation relieves high-fat diet-induced liver steatosis by reducing energy metabolism and promoting lipolysis. J Nutr Biochem. 2021 08; 94:108645.
-
Apobec1 complementation factor overexpression promotes hepatic steatosis, fibrosis, and hepatocellular cancer. J Clin Invest. 2021 01 04; 131(1).
-
Susceptibility of Rat Steatotic Liver to Ischemia-Reperfusion Is Treatable With Liver-Selective Matrix Metalloproteinase Inhibition. Hepatology. 2020 11; 72(5):1771-1785.
-
Leptin decreases de novo lipogenesis in patients with lipodystrophy. JCI Insight. 2020 07 23; 5(14).
-
Partial leptin deficiency confers resistance to diet-induced obesity in mice. Mol Metab. 2020 07; 37:100995.